429 studies found for:    Open Studies | "Arthritis, Rheumatoid"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Arthritis, Rheumatoid"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Predictive Value of Ultrasound in Early Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis;   Predictive Value of Ultrasound in Early Rheumatoid Arthritis
Intervention:
2 Recruiting An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis
Conditions: Arthritis;   Arthritis, Rheumatoid;   Joint Diseases;   Musculoskeletal Diseases;   Rheumatic Diseases;   Connective Tissue Diseases;   Autoimmune Diseases
Interventions: Procedure: Magnetic resonance imaging (MRI);   Other: Conventional biochemical and clinical examinations
3 Not yet recruiting Preliminary Study of Sonic Hedgehog Signaling Pathway in the Pathogenesis of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Neovascularization, Pathologic;   Synovitis
Intervention:
4 Recruiting A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Drug: Sirukumab
5 Not yet recruiting Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: Tocilizumab
6 Recruiting A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®)
Condition: Arthritis, Rheumatoid
Intervention: Biological: Golimumab 2 mg/kg IV
7 Recruiting A Study Comparing Sirukumab (CNTO 136) Monotherapy With Adalimumab (HUMIRA®) Monotherapy in the Treatment of Active Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Biological: adalimumab 40 mg;   Biological: sirukumab 100 mg;   Biological: sirukumab 50 mg;   Drug: Placebo
8 Unknown  Vitamin D Deficiency Causes Immune Dysfunction and Enables or Perpetuates the Development of Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid;   Vitamin D Deficiency
Interventions: Drug: Placebo in arm A and Vitamin D in arm B;   Drug: vitamin D 3 for arm A ,and matching placebo for arm B
9 Recruiting Effectiveness and Safety of Physical Exercises in the Improvement of the Sleep Efficiency Regarding Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Other: Combined Training ( Strength + Aerobics)
10 Recruiting A Study of CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Placebo;   Drug: Sirukumab
11 Not yet recruiting Evaluation of the Intestinal Microbiota and Bacterial Translocation in Patients With DR4 Homozygous Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Biological: Plasma analysis for bacterial translocation;   Biological: Stool analysis
12 Recruiting Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP-690,550
13 Recruiting Efficacy and Safety Study of ABP 501 Compared to Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: ABP 501;   Drug: Adalimumab (Humira®)
14 Recruiting Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: ABP 501
15 Recruiting Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: tofacitinib;   Biological: adalimumab;   Biological: etanercept
16 Recruiting Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: BI 695500
17 Recruiting Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: BI 695500;   Drug: rituximab
18 Unknown  Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity Syndromes
Conditions: Fatigue Syndrome, Chronic;   Fibromyalgia;   Arthritis, Rheumatoid
Interventions: Drug: citalopram;   Drug: 1 ml 0.9 % NaCl
19 Unknown  A Study to Validate Questionnaires FLARE and OM-RA-FLARE Measuring Disease Flares in Patients With Rheumatoid Arthritis.
Condition: Arthritis, Rheumatoid
Intervention: Other: Questionnaire
20 Recruiting A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)
Condition: Arthritis, Rheumatoid
Interventions: Drug: Etoricoxib 60 mg;   Drug: Etoricoxib 90 mg;   Drug: Placebo to Etoricoxib 60 mg;   Drug: Placebo to Etoricoxib 90 mg

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years